Design	O
and	O
synthesis	O
of	O
phosphoryl	B:C1254351
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	O
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	O
treatment	I:C2985566
of	O
B	O
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
.	O

Design	O
and	O
synthesis	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	B:C1254351
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	O
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	O
treatment	I:C2985566
of	O
B	O
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
.	O

Design	O
and	O
synthesis	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	B:C4041516
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	O
treatment	I:C2985566
of	O
B	O
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
.	O

Design	O
and	O
synthesis	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	O
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	B:C2985566
treatment	I:C2985566
of	O
B	O
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
.	O

Design	O
and	O
synthesis	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	O
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	O
treatment	I:C2985566
of	O
B	B:C2004493
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
.	O

Design	O
and	O
synthesis	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
(	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidines	I:C1254351
)	O
as	O
potent	O
Bruton	O
's	I:C4041516
tyrosine	I:C4041516
kinase	I:C4041516
(	I:C4041516
BTK	I:C4041516
)	I:C4041516
inhibitors	I:C4041516
:	O
Targeted	O
treatment	I:C2985566
of	O
B	O
lymphoblastic	I:C2004493
leukemia	I:C2004493
cell	B:C0007634
lines	I:C0007634
.	O

A	O
family	O
of	O
phosphoryl	B:C1254351
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidine	I:C1254351
derivatives	I:C1254351
(	I:C1254351
Pho	I:C1254351
-	I:C1254351
DPPYs	I:C1254351
)	I:C1254351
were	O
synthesized	O
and	O
biologically	O
evaluated	O
as	O
potent	O
BTK	O
inhibitors	I:C4041516
in	O
this	O
study	O
.	O

A	O
family	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidine	I:C1254351
derivatives	I:C1254351
(	I:C1254351
Pho	I:C1254351
-	I:C1254351
DPPYs	I:C1254351
)	I:C1254351
were	O
synthesized	O
and	O
biologically	O
evaluated	B:C0220825
as	O
potent	O
BTK	O
inhibitors	I:C4041516
in	O
this	O
study	O
.	O

A	O
family	O
of	O
phosphoryl	O
-	I:C1254351
substituted	I:C1254351
diphenylpyrimidine	I:C1254351
derivatives	I:C1254351
(	I:C1254351
Pho	I:C1254351
-	I:C1254351
DPPYs	I:C1254351
)	I:C1254351
were	O
synthesized	O
and	O
biologically	O
evaluated	O
as	O
potent	O
BTK	B:C4041516
inhibitors	I:C4041516
in	O
this	O
study	O
.	O

Compound	B:C1254351
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	B:C0218158
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	B:C0243102
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	B:C0596290
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	B:C2004493
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	B:C0007634
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	B:C0007634
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	B:C1514716
)	O
expressing	O
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	B:C1171362
high	O
levels	O
of	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Compound	O
7b	I:C1254351
was	O
found	O
to	O
markedly	O
inhibit	O
Bruton	O
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
activity	O
at	O
concentrations	O
of	O
0.82	O
nmol	O
/	O
L	O
,	O
as	O
well	O
as	O
to	O
suppress	O
the	O
proliferations	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
leukemia	I:C2004493
cell	O
lines	I:C0007634
(	O
Ramos	O
and	O
Raji	O
)	O
expressing	O
high	O
levels	O
of	O
Bruton	B:C0218158
's	I:C0218158
tyrosine	I:C0218158
kinase	I:C0218158
at	O
concentrations	O
of	O
3.17μM	O
and	O
6.69μM	O
.	O

Moreover	O
,	O
flow	B:C0200904
cytometry	I:C0200904
analysis	I:C0200904
results	O
further	O
indicated	O
that	O
7b	O
promoted	O
cell	O
apoptosis	I:C1326202
to	O
a	O
substantial	O
degree	O
.	O

Moreover	O
,	O
flow	O
cytometry	I:C0200904
analysis	I:C0200904
results	O
further	O
indicated	O
that	O
7b	B:C1254351
promoted	O
cell	O
apoptosis	I:C1326202
to	O
a	O
substantial	O
degree	O
.	O

Moreover	O
,	O
flow	O
cytometry	I:C0200904
analysis	I:C0200904
results	O
further	O
indicated	O
that	O
7b	O
promoted	O
cell	B:C1326202
apoptosis	I:C1326202
to	O
a	O
substantial	O
degree	O
.	O

In	O
a	O
word	O
,	O
compound	B:C1254351
7b	I:C1254351
is	O
a	O
promising	O
BTK	O
inhibitor	I:C4041516
for	O
the	O
treatment	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
lymphoblastic	I:C2004493
leukemia	I:C2004493
.	O

In	O
a	O
word	O
,	O
compound	O
7b	I:C1254351
is	O
a	O
promising	O
BTK	B:C4041516
inhibitor	I:C4041516
for	O
the	O
treatment	O
of	O
B	O
-	I:C2004493
cell	I:C2004493
lymphoblastic	I:C2004493
leukemia	I:C2004493
.	O

In	O
a	O
word	O
,	O
compound	O
7b	I:C1254351
is	O
a	O
promising	O
BTK	O
inhibitor	I:C4041516
for	O
the	O
treatment	B:C0087111
of	O
B	O
-	I:C2004493
cell	I:C2004493
lymphoblastic	I:C2004493
leukemia	I:C2004493
.	O

In	O
a	O
word	O
,	O
compound	O
7b	I:C1254351
is	O
a	O
promising	O
BTK	O
inhibitor	I:C4041516
for	O
the	O
treatment	O
of	O
B	B:C2004493
-	I:C2004493
cell	I:C2004493
lymphoblastic	I:C2004493
leukemia	I:C2004493
.	O

